Publicacións en colaboración con investigadores/as de University of Gothenburg (54)

2025

  1. A head-to-head comparison of plasma biomarkers to detect Alzheimer's disease in a memory clinic

    Alzheimer's & dementia : the journal of the Alzheimer's Association, Vol. 21, Núm. 2, pp. e14609

  2. Hypometabolism and atrophy patterns associated with Niemann-Pick type C

    EJNMMI Research, Vol. 15, Núm. 1

  3. The effect of Lewy body (co-)pathology on the clinical and imaging phenotype of amnestic patients

    Brain, Vol. 148, Núm. 7, pp. 2441-2452

  4. Validating the PECARN rule to identify febrile infants at low risk of serious bacterial infections: an international validation study

    Archives of Disease in Childhood

2024

  1. Partial volume correction in longitudinal tau PET studies: is it really needed?

    NeuroImage, Vol. 289

  2. Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care

    The Journal of rheumatology, Vol. 51, Núm. 4, pp. 378-389

  3. Quantitative brain [18F]FDG PET beyond normal blood glucose levels

    NeuroImage, Vol. 300

  4. Time-encoded ASL reveals lower cerebral blood flow in the early AD continuum

    Alzheimer's and Dementia, Vol. 20, Núm. 8, pp. 5183-5197

2023

  1. Blood-brain barrier integrity impacts the use of plasma amyloid-β as a proxy of brain amyloid-β pathology

    Alzheimer's and Dementia, Vol. 19, Núm. 9, pp. 3815-3825

  2. Clinical performance and head-to-head comparison of CSF p-tau235 with p-tau181, p-tau217 and p-tau231 in two memory clinic cohorts

    Alzheimer's Research and Therapy, Vol. 15, Núm. 1

  3. Exploring the Impact of Covid-19-Related Perceptions on Psychological Distress and Quality of Life in an International Gastrointestinal Cohort Over Time Guided by the Common Sense Model

    Journal of Clinical Psychology in Medical Settings, Vol. 30, Núm. 4, pp. 804-820

  4. One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment

    Journal of Rheumatology, Vol. 50, Núm. 8, pp. 1009-1019

  5. Plasma and CSF biomarkers in a memory clinic: Head-to-head comparison of phosphorylated tau immunoassays

    Alzheimer's and Dementia, Vol. 19, Núm. 5, pp. 1913-1924

  6. Position statement: Recommendations on the diagnosis and treatment of Malassezia folliculitis

    Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 7, pp. 1268-1275

2022

  1. 18F-florbetapir PET as a marker of myelin integrity across the Alzheimer’s disease spectrum

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 49, Núm. 4, pp. 1242-1253

  2. Extending the Common Sense Model to Explore the Impact of the Fear of COVID-19 on Quality of Life in an International Inflammatory Bowel Disease Cohort

    Journal of Clinical Psychology in Medical Settings, Vol. 29, Núm. 3, pp. 678-688

  3. Impact of spill-in counts from off-target regions on [18F]Flortaucipir PET quantification

    NeuroImage, Vol. 259

  4. Multi-Ancestry GWAS reveals excitotoxicity associated with outcome after ischaemic stroke

    Brain, Vol. 145, Núm. 7, pp. 2394-2406

  5. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  6. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123